MX2022011400A - Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento. - Google Patents

Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento.

Info

Publication number
MX2022011400A
MX2022011400A MX2022011400A MX2022011400A MX2022011400A MX 2022011400 A MX2022011400 A MX 2022011400A MX 2022011400 A MX2022011400 A MX 2022011400A MX 2022011400 A MX2022011400 A MX 2022011400A MX 2022011400 A MX2022011400 A MX 2022011400A
Authority
MX
Mexico
Prior art keywords
capsaicinoid
responders
capsaicin
topical application
concentration capsaicin
Prior art date
Application number
MX2022011400A
Other languages
English (en)
Inventor
Marielle Eerdekens
Sylvia Engelen
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Publication of MX2022011400A publication Critical patent/MX2022011400A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención hace referencia al tratamiento repetido de una afección neuropática, preferentemente dolor neuropático periférico, mediante la aplicación de una o más unidades de dosis tópicas de capsaicinoide y/o capsaicinas de alta concentración, preferentemente parches de capsaicinoide y/o capsaicina de alta concentración, a pacientes que previamente no respondieron o respondieron de manera insuficiente a una aplicación previa de una o más unidades de dosis tópicas de capsaicinoide y/o capsaicinas de alta concentración, preferentemente parches de capsaicinoide y/o capsaicina de alta concentración o cualquier otra formulación de capsaicinoide y/o capsaicina de alta concentración administrada previamente en forma tópica.
MX2022011400A 2020-03-17 2021-03-17 Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento. MX2022011400A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP20163651 2020-03-17
EP20167982 2020-04-03
EP20173133 2020-05-06
PCT/EP2021/056776 WO2021185887A1 (en) 2020-03-17 2021-03-17 Repeated topical application of capsaicin patch for treating initial non-responders

Publications (1)

Publication Number Publication Date
MX2022011400A true MX2022011400A (es) 2022-10-13

Family

ID=74871416

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022011400A MX2022011400A (es) 2020-03-17 2021-03-17 Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento.

Country Status (11)

Country Link
US (1) US20230157977A1 (es)
EP (1) EP4121027A1 (es)
JP (1) JP2023517745A (es)
KR (1) KR20220154160A (es)
CN (1) CN115297853A (es)
AU (1) AU2021238637A1 (es)
BR (1) BR112022018608A2 (es)
CA (1) CA3175582A1 (es)
CL (1) CL2022002538A1 (es)
MX (1) MX2022011400A (es)
WO (1) WO2021185887A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023178413A1 (en) * 2022-03-21 2023-09-28 360Medlink Inc. A method and a system for monitoring a treatment area of a patient

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6239180B1 (en) 1995-11-08 2001-05-29 The Regents Of The University Of California Transdermal therapeutic device and method with capsaicin and capsaicin analogs
US6248788B1 (en) 1996-11-06 2001-06-19 The Regents Of The University Of California Therapeutic method with capsaicin and capasicin analogs
PT1605956E (pt) 2002-12-18 2016-03-09 Centrexion Therapeutics Corp Administração de capsaicinóides para o tratamento da osteoartrite
JP4931128B2 (ja) 2003-04-10 2012-05-16 ニューロジェシックス， インコーポレイテッド Ｔｒｐｖ１アゴニストの投与のための方法および組成物
CA2517493C (en) 2003-04-14 2011-05-31 Walter Mueller Therapeutic patch with polysiloxane matrix comprising capsaicin
JP5148271B2 (ja) 2004-06-02 2013-02-20 ニューロジズエックス，インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物
PT1865941E (pt) 2005-04-01 2011-01-05 Neurogesx Inc Óleos de capsaicinóides e métodos para a sua produção e utilização
KR101769010B1 (ko) 2011-09-09 2017-08-17 비쭈리 헬스 사이언스 엘엘씨 Trpv1 선택적 작용제를 포함하는 통증 완화 조성물, 및 이의 제조방법 및 용도
CA2945818C (en) 2014-04-15 2022-05-03 Vizuri Health Sciences Llc Topical compositions comprising a capsaicinoid for pain relief, manufacture and use

Also Published As

Publication number Publication date
US20230157977A1 (en) 2023-05-25
CN115297853A (zh) 2022-11-04
WO2021185887A1 (en) 2021-09-23
BR112022018608A2 (pt) 2022-11-08
CL2022002538A1 (es) 2023-04-21
JP2023517745A (ja) 2023-04-26
EP4121027A1 (en) 2023-01-25
AU2021238637A1 (en) 2022-11-10
KR20220154160A (ko) 2022-11-21
CA3175582A1 (en) 2021-09-23

Similar Documents

Publication Publication Date Title
EA201650134A1 (ru) Специфическая сочетанная терапия злокачественных опухолей цитостатиком и его модификатором
WO2015066647A3 (en) Ionic liquids for transdermal drug delivery
PH12020551597A1 (en) Treatment of hidradenitis suppurativa using jak inhibitors
BR0006024A (pt) Composição para o tratamento de inflamação e dor em mamìferos
MX2021008974A (es) Tratamiento para los trastornos de la piel con composiciones combinadas tópicas de tapinarof.
RU2017120184A (ru) Лекарства для замедления течения болезни паркинсона
MX2023003678A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2022011400A (es) Aplicacion topica repetida de parche de capsaicina para usarse para tratar pacientes que no responden inicialmente al tratamiento.
MX2020001768A (es) Metodos de tratamiento de la osteoartritis con gel de canabidiol transdermico.
Mishra et al. Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study
MX2023003677A (es) Inhibidores de hidroxiesteroide 17beta- deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2019002047A (es) Metodos y composiciones para tratar infecciones fungicas cutaneas.
MX2020011295A (es) Tratamiento de dermatitis atopica.
CR20210514A (es) USO DE REBOXETINA PARA EL TRATAMIENTO DE NARCOLEPSIA (Divisional 2021-0183)
MX2023003675A (es) Inhibidores de hidroxiesteroide 17beta-deshidrogenasa 13 (hsd17b13) y usos de estos.
MX2021003651A (es) Formulacion que comprende aceite ozonizado en el tratamiento de un tumor.
BR112022009794A2 (pt) Método para tratar câncer no pulmão
MX2022012219A (es) Regimen para la aplicacion topica repetida del parche de capsaicina.
MX2021016043A (es) Formulacion de doxorrubicina liposomal, metodo para producir una formulacion de doxorrubicina liposomal y uso de una formulacion de doxorrubicina liposomal como un medicamento.
MX2022006630A (es) Uso de reboxetina para tratar los trastornos del sistema nervioso.
KR20230090185A (ko) 위 점막 병변을 동반한 류마티스 관절염을 치료하는 약제학적 복합제제
WO2022025785A8 (ru) Фармацевтическая композиция, включающая мемантин и цитиколин
MX2023005681A (es) Composicion farmaceutica para el tratamiento contra el dolor agudo y cronico, que contiene polmacoxib y tramadol.
MX2022010593A (es) Composiciones tópicas de diclofenaco y métodos.
KR20220085086A (ko) 갑상선 기능 저하증을 동반한 대사 증후군을 치료하는 약제학적 복합제제